In 2023, the number of notified tuberculosis cases in the US stood at a benchmark level, and based on forecast data from 2024 to 2028, there is a consistent downward trend predicted in the number of cases. Year-over-year variations indicate a steady decline of approximately 4.57% annually. The 5-year compounded annual growth rate (CAGR) also reflects this gradual decrease, suggesting a proactive approach being taken within the healthcare system to manage and reduce TB cases in the US.

Future trends to watch for:

Impact of new healthcare policies and funding on TB prevention and treatment.
Innovations in medical research and technology that could accelerate TB detection and treatment.
Socioeconomic factors influencing the transmission and reporting of TB cases.